Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6237 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
78-1   / Orion Corporation Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-2   / B BRAUN MEDICAL INC Original drug not imported to China US Orange Book The 78th Batch of Reference Listed Drugs
78-3   Tepmetko Merck Europe B.V. Original drug not imported to China Approved in EU The 78th Batch of Reference Listed Drugs
78-4   ALLELOCK OD Tablets Kyowa Kirin Co., Ltd. (協和キリン株式会社) Original drug not imported to China Approved in Japan The 78th Batch of Reference Listed Drugs
78-5   / Kyowa Kirin Co., Ltd. (協和キリン株式会社) Original drug not imported to China Approved in Japan The 78th Batch of Reference Listed Drugs
78-6   / SEPTODONT Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-7   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-8   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-9   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs
78-10   / AstraZeneca AB Original drug approved in China Original drug imported to China The 78th Batch of Reference Listed Drugs